The Effectiveness and Safety of the Short‐Course Therapy in Liver Transplant Recipients With Uncomplicated Gram‐Negative Bacteremia: A Retrospective Study
Transplant Infectious Disease · 2025
DOI: 10.1111/tid.14434 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, 2025. Verfasst von Toshiki Miwa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, The University of Tokyo Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Liver Transplantation, Bacteremia, Anti-Bacterial Agents, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Introduction
The appropriate duration of therapy for uncomplicated gram‐negative bloodstream infection (GN‐BSI) in liver transplant (LTx) recipients remains unknown. This study aims to explore the effectiveness of a short‐course antimicrobial therapy.
Methods
This retrospective study was performed in a single LTx center in Japan. All LTx recipients with GN‐BSI receiving 6–16 days of therapy with adequate source control between 2010 and 2022 were included. We collected data on demographics, underlying medical conditions, clinical manifestations, laboratory and microbiology data, ID consultation, oral switch therapy, and subsequent clinical course through chart review. We compared the 30‐day composite outcome comprising mortality and recurrence of BSI or local infection between patients receiving a short‐course (6–10 days) therapy and those receiving a long‐course (11–16 days) therapy.
Results
Of 91 study participants, 27 (29.7%) and 64 (70.3%) received short‐course and long‐course antimicrobial therapy, respectively. Cholangitis was the most common source of BSI (57/91 [62.6%]). Overall, the primary composite outcome occurred in 18 patients (19.8%), most of which was the recurrence of local infection ( n = 14). The primary composite outcome was numerically compatible between these groups (5/27 [18.5%] vs. 13/64 [20.3%]; p = 0.84).
Conclusions
A short‐course therapy may be an effective option in selected LTx recipients with uncomplicated GN‐BSI. Whether a short‐course oral switch therapy is a viable option or not warrants further research. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, The University of Tokyo Hospital, Tokyo, Japan.
- Department of Infectious Diseases, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
- Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Toshiki Miwa
Förderung
- JSPS KAKENHI
Zitieren
APA
Miwa, T., Okamoto, K., Ishikawa, S., Ikeuchi, K., Yamamoto, S., Ikeda, M., Okugawa, S., Ichida, A., Akamatsu, N., Hasegawa, K., & Tsutsumi, T. (2025). The Effectiveness and Safety of the Short‐Course Therapy in Liver Transplant Recipients With Uncomplicated Gram‐Negative Bacteremia: A Retrospective Study. Transplant Infectious Disease. https://doi.org/10.1111/tid.14434
Vancouver
Miwa T, Okamoto K, Ishikawa S, Ikeuchi K, Yamamoto S, Ikeda M, et al. The Effectiveness and Safety of the Short‐Course Therapy in Liver Transplant Recipients With Uncomplicated Gram‐Negative Bacteremia: A Retrospective Study. Transplant Infectious Disease. 2025. doi:10.1111/tid.14434
BibTeX
@article{Miwa2025,
author = {Miwa, Toshiki and Okamoto, Koh and Ishikawa, Shotaro and Ikeuchi, Kazuhiko and Yamamoto, Shinya and Ikeda, Mahoko and Okugawa, Shu and Ichida, Akihiko and Akamatsu, Nobuhisa and Hasegawa, Kiyoshi and Tsutsumi, Takeya},
title = {The Effectiveness and Safety of the Short‐Course Therapy in Liver Transplant Recipients With Uncomplicated Gram‐Negative Bacteremia: A Retrospective Study},
journal = {Transplant Infectious Disease},
year = {2025},
doi = {10.1111/tid.14434}
}
EUVIMED